Locations:
SearchAdvertisement
Systems genetics approach sets stage for lab testing of simvastatin and other candidate drugs
Open-source artificial intelligence technology uses human genetic data to find candidate drugs
Findings underscore need for racial diversity in ongoing and future trials
$14M NIH grant supports research toward medications to prevent progression
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
BACE1 inhibitor reduces cancer progression in models of glioblastoma
69% relative risk reduction in large database analysis prompts plans for mechanistic and phase 2 studies
Minimizing the translational gap between preclinical testing and clinical outcomes
deepDTnet receives provisional patent to accelerate drug repurposing and minimize the translational gap in development
Advertisement
Advertisement